The global adhesion barrier market is poised for significant growth, projected to expand from $0.7 billion in 2023 to $0.9 billion by 2028, at a compound annual growth rate (CAGR) of 7.4%. This upward trajectory is fueled by several key factors, including an aging global population, a surge in surgical procedures and sports-related injuries, and heightened awareness of adhesion formation complications.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
Market Drivers and Challenges
The primary driver propelling the adhesion barrier market’s growth is the increasing volume of surgeries and sports-related injuries worldwide. Adhesion formation is a common post-surgical complication, often necessitating repeat surgeries for treatment. As the number of surgeries rises, so does the demand for effective adhesion barriers to mitigate these complications.
However, the market faces a notable challenge: the reluctance of some surgeons to adopt adhesion barriers due to limited reliable clinical evidence supporting the safety and efficacy of currently available products. Additionally, stringent regulations have hindered technological innovations, further exacerbating the issue.
Geographical Landscape
While the adhesion barrier market is witnessing growth globally, the Asia-Pacific region is expected to experience the fastest expansion during the forecast period. Factors such as rapid economic growth, the presence of universal healthcare reimbursement policies, and an increasing disease prevalence are driving the demand for advanced medical technologies in this region.
Key Market Segments
The synthetic adhesion barrier product segment is anticipated to experience the highest growth rate during the forecast period, attributed to its resorbable nature and cost-effectiveness compared to natural adhesion barriers.
In terms of formulation, film-based adhesion barriers held the largest market share in 2022, owing to their wide availability, strong clinical evidence supporting their safety and efficacy, and ease of use.
Hospitals and clinics dominated the market in 2022, reflecting the high volume of surgical procedures performed in these settings.
Untapped Opportunities
Emerging markets in regions like Asia-Pacific, Latin America, and the Middle East and Africa present significant untapped opportunities for players in the adhesion barrier market. These regions have a large patient base for target indications, such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders, coupled with an increasing number of surgical procedures being performed.
Key Players
Prominent players in the adhesion barrier market include Baxter International, Johnson & Johnson, Becton, Dickinson and Company, Integra LifeSciences, Anika Therapeutics, Atrium Medical Corporation, FzioMed, MAST Biosurgery, Innocoll, Betatech Medical, CorMatrix Cardiovascular, Inc., Terumo Corporation, BiosCompass, W.L.Gore & Associates, GUNZE Limited, Leader Biomedical, Xlynk Surgical, Luna Solutions, PlantTec Medical GmbH, Actamax Surgical Materials, LLC, Arc Medical Devices, INC., CG Bio INC., Seikagaku Corporation, Hangzhou Singclean Medical Products Co.,Ltd, and Allosource.
As the global healthcare landscape continues to evolve, the adhesion barrier market is poised to play a crucial role in mitigating post-surgical complications, driving innovation, and improving patient outcomes worldwide.
